Han You

5.8k total citations · 1 hit paper
41 papers, 4.5k citations indexed

About

Han You is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Han You has authored 41 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Han You's work include FOXO transcription factor regulation (13 papers), Cancer-related Molecular Pathways (6 papers) and Epigenetics and DNA Methylation (6 papers). Han You is often cited by papers focused on FOXO transcription factor regulation (13 papers), Cancer-related Molecular Pathways (6 papers) and Epigenetics and DNA Methylation (6 papers). Han You collaborates with scholars based in China, United States and Canada. Han You's co-authors include Tak W. Mak, Arnold J. Levine, Megan Cully, Kazuo Yamamoto, Zhaohui Feng, Xin Jin, Andreas Villunger, Georg Häcker, Miriam Erlacher and Katsuya Tsuchihara and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Han You

40 papers receiving 4.4k citations

Hit Papers

Beyond PTEN mutations: the PI3K pathway as an integrator ... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han You China 29 3.4k 1.1k 955 476 470 41 4.5k
Youngkyu Park South Korea 35 2.9k 0.8× 1.4k 1.3× 1.0k 1.1× 608 1.3× 339 0.7× 88 5.0k
Dung‐Fang Lee United States 36 4.9k 1.4× 1.6k 1.4× 1.4k 1.5× 660 1.4× 417 0.9× 87 6.3k
Peiqing Sun United States 41 3.6k 1.1× 1.2k 1.1× 991 1.0× 668 1.4× 324 0.7× 84 5.0k
Darjus F. Tschaharganeh Germany 22 2.3k 0.7× 1.1k 1.0× 583 0.6× 538 1.1× 349 0.7× 34 3.5k
Sandra E. Dunn Canada 43 3.5k 1.0× 1.5k 1.4× 1.1k 1.2× 339 0.7× 310 0.7× 99 5.1k
Shuichi Tsutsumi Japan 43 4.4k 1.3× 773 0.7× 1.2k 1.2× 452 0.9× 305 0.6× 83 5.8k
Masahiro Aoki Japan 31 3.6k 1.0× 1.3k 1.2× 824 0.9× 752 1.6× 230 0.5× 71 4.9k
Akihiro Kurimasa Japan 36 4.8k 1.4× 1.6k 1.5× 1.2k 1.2× 399 0.8× 597 1.3× 90 6.3k
Gerta Hoxhaj United States 18 2.7k 0.8× 456 0.4× 878 0.9× 329 0.7× 383 0.8× 24 3.7k
Ron Firestein United States 35 2.9k 0.9× 1.2k 1.1× 679 0.7× 273 0.6× 315 0.7× 59 4.3k

Countries citing papers authored by Han You

Since Specialization
Citations

This map shows the geographic impact of Han You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han You more than expected).

Fields of papers citing papers by Han You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han You. The network helps show where Han You may publish in the future.

Co-authorship network of co-authors of Han You

This figure shows the co-authorship network connecting the top 25 collaborators of Han You. A scholar is included among the top collaborators of Han You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han You. Han You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Changqing, Yue Liu, Wenju Liu, et al.. (2022). NNMT‐DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition. Advanced Science. 10(1). e2202642–e2202642. 29 indexed citations
2.
Gong, Zhicheng, Jian‐cheng Ding, Qing Li, et al.. (2021). OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis. Advanced Science. 8(15). e2004504–e2004504. 43 indexed citations
3.
Goiran, Thomas, Eric Duplan, Inger Lauritzen, et al.. (2018). Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation. Cell Death and Differentiation. 25(5). 873–884. 98 indexed citations
4.
Liang, Shan, Hu Chen, Tao� Lv, et al.. (2017). ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis. Proceedings of the National Academy of Sciences. 114(20). E3964–E3973. 52 indexed citations
5.
Tran, Charles W., Samuel D. Saibil, Thierry Le Bihan, et al.. (2017). Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation. The Journal of Immunology. 199(12). 4056–4065. 13 indexed citations
7.
Zhang, Lanjun, Qixu Cai, Chen Zhao, et al.. (2016). Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71. Journal of Molecular Recognition. 29(11). 520–527. 5 indexed citations
8.
Zhang, Lei, Yang Mei, Nai Yang Fu, et al.. (2012). TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21. Proceedings of the National Academy of Sciences. 109(51). 20937–20942. 40 indexed citations
9.
Mei, Yang, Yiru Zhang, Kazuo Yamamoto, et al.. (2009). FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proceedings of the National Academy of Sciences. 106(13). 5153–5158. 143 indexed citations
10.
Cully, Megan, Han You, Arnold J. Levine, & Tak W. Mak. (2006). Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature reviews. Cancer. 6(3). 184–192. 984 indexed citations breakdown →
11.
Levine, Arnold J., Zhaohui Feng, Tak W. Mak, Han You, & Xin Jin. (2006). Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways. Genes & Development. 20(3). 267–275. 268 indexed citations
12.
You, Han, Marc Pellegrini, Katsuya Tsuchihara, et al.. (2006). FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. The Journal of Experimental Medicine. 203(7). 1657–1663. 342 indexed citations
13.
You, Han, Kazuo Yamamoto, & Tak W. Mak. (2006). Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proceedings of the National Academy of Sciences. 103(24). 9051–9056. 125 indexed citations
14.
Sweet‐Cordero, E. Alejandro, George C. Tseng, Han You, et al.. (2005). Comparison of gene expression and DNA copy number changes in a murine model of lung cancer. Genes Chromosomes and Cancer. 45(4). 338–348. 29 indexed citations
15.
Hahn, Hyewon, et al.. (2004). A Case of Transient Pseudohypoaldosteronism Secondary to Ureteropelvic Junction Obstruction. 8(1). 91–95. 2 indexed citations
16.
You, Han & Tak W. Mak. (2004). Crosstalk between p53 and FOXO Transcription Factors. Cell Cycle. 4(1). 37–38. 80 indexed citations
17.
Jung, Dae Soo, Jae‐Hyeok Lee, Jieun Lee, et al.. (2004). Corneal Endothelial Changes as a Clinical Diagnostic Indicator of Dentatorubropallidoluysian Atrophy. Cornea. 23(2). 210–214. 3 indexed citations
18.
Sweet‐Cordero, E. Alejandro, Sayan Mukherjee, Aravind Subramanian, et al.. (2004). An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nature Genetics. 37(1). 48–55. 314 indexed citations
19.
Zheng, Hongwu, Han You, Xiao Zhen Zhou, et al.. (2002). The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature. 419(6909). 849–853. 323 indexed citations
20.
Zhao, Yanqiu, Han You, Fei Liu, et al.. (2002). Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Letters. 185(2). 211–218. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026